Research and Clinical Trials

  • Clinical Trials

    Clinical trials are research studies designed to find new and better ways to treat patients with cancer and other diseases.

  • Research Programs

    Cancer Research at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

  • Immunotherapy

    UMGCCC gives patients access to many different forms of immunotherapy. An immunotherapy is any therapy that trains a patient's own immune system to detect and destroy cancer cells. Many of our physicians are principal investigators in immunotherapy clinical trials, making UMGCCC one of the region's leaders in this growing area of cancer treatment research.

  • Shared Services

    The mission of the Genomics Shared Service is to enable and foster institutional science by providing the expertise, state-of-the-art resources, and the training necessary to promote cutting edge genomic research.
  • Training and Education

    The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) fosters a stimulating, multidisciplinary education and training environment through active participation in the training of graduate students, medical students, residents and fellows, mentoring of junior faculty, and sponsoring of cancer-related educational and training activities.

  • Postdoctoral Fellowships

    UMGCCC has available several postdoctoral fellowships in basic and translational cancer biology research. These positions are open to any doctoral-level student, although the positions supported by the NIH NCI T32 Training Grant are open only to citizens and permanent residents of the United States.

  • Clinical Research Management Office

    Clinical research is an essential part of the mission of the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC). 

  • Scientific and Safety Review

    Clinical research at UMGCCC is governed by several committees that comprise the NCI-required Protocol Review and Monitoring System (PRMS).

  • Program in Oncology Leadership

    Leadership for the UM Greenebaum Comprehensive Cancer Center Program in Oncology.

  • Frontiers in Oncology Seminars

    The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.

  • Researchers' Toolkit

    The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center's grants administration office offers the tools necessary to assist researchers.

  • Cigarette Restitution Fund Program

    In 1999 the Maryland General Assembly announced a 10-year, $1 billion comprehensive plan to use tobacco settlement funds to conquer cancer and other tobacco-related diseases.
  • ACS Institutional Research Grants

    The American Cancer Society Institutional Research Grant Provides "Seed Money" to Support New Investigators
  • UMGCCC Research Day

    UMGCCC Research Day consists of a series of talks about our research programs, the UM Cancer Network and how the University of Maryland is affecting cancer care in Maryland.